These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 36297490)

  • 1. Evaluation of Newly Designed and Traditional Punches in Manufacturing of Scored ODTs.
    Palugan L; Moutaharrik S; Maroni A; Foppoli AA; Melocchi A; Vecchio C; Gazzaniga A; Cerea M
    Pharmaceutics; 2022 Sep; 14(10):. PubMed ID: 36297490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized furosemide taste masked orally disintegrating tablets.
    Ibrahim MA; Abou El Ela AESF
    Saudi Pharm J; 2017 Nov; 25(7):1055-1062. PubMed ID: 29158715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new modified wetting test and an alternative disintegration test for orally disintegrating tablets.
    Hooper P; Lasher J; Alexander KS; Baki G
    J Pharm Biomed Anal; 2016 Feb; 120():391-6. PubMed ID: 26774944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a superdisintegrant on disintegration of orally disintegrating tablets determined by simulated wetting test and
    Sutthapitaksakul L; Thanawuth K; Huanbutta K; Sriamornsak P
    Pharmazie; 2022 Oct; 77(10):287-290. PubMed ID: 36273260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ease of Taking and Palatability of Fixed-Dose Orally Disintegrating Mitiglinide/Voglibose Tablets.
    Sotoyama M; Uchida S; Kamiya C; Tanaka S; Kashiwagura Y; Hakamata A; Odagiri K; Inui N; Watanabe H; Namiki N
    Chem Pharm Bull (Tokyo); 2019; 67(6):540-545. PubMed ID: 31155559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and Evaluation of Directly Compressible Orally Disintegrating Tablets of Cannabidiol Formulated Using Liquisolid Technique.
    Limpongsa E; Tabboon P; Pongjanyakul T; Jaipakdee N
    Pharmaceutics; 2022 Nov; 14(11):. PubMed ID: 36365225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and Evaluation of Baclofen-Meloxicam Orally Disintegrating Tablets (ODTs) Using Co-Processed Excipients and Improvement of ODTs Performance Using Six Sigma Method.
    Abdelmonem R; Abdellatif MM; Al-Samadi IEI; El-Nabarawi MA
    Drug Des Devel Ther; 2021; 15():4383-4402. PubMed ID: 34690500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of metformin hydrochloride- and glyburide-containing orally disintegrating tablets.
    Gulsun T; Akdag Y; Izat N; Cetin M; Oner L; Sahin S
    Pharm Dev Technol; 2020 Oct; 25(8):999-1009. PubMed ID: 32431206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
    Gulsun T; Ozturk N; Kaynak MS; Vural I; Sahin S
    Pharmazie; 2017 Jul; 72(7):389-394. PubMed ID: 29441935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of tablet punch configuration on mitigating capping by a quality by design approach.
    Desai PM; Anbalagan P; Koh CJN; Heng PWS; Liew CV
    Drug Deliv Transl Res; 2018 Dec; 8(6):1635-1643. PubMed ID: 28849387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril maleate orally disintegrating tablets: tableting and in vivo evaluation in hypertensive rats.
    Tawfeek HM; Faisal W; Soliman GM
    Pharm Dev Technol; 2018 Jun; 23(5):496-503. PubMed ID: 28489472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Orally Disintegrating Tablets Using Erythritol as an Excipient Produced by Moisture-Activated Dry Granulation (MADG).
    Yamada M; Ishikawa A; Muramatsu S; Furuishi T; Onuki Y; Fukuzawa K; Yonemochi E
    Pharmaceuticals (Basel); 2022 Aug; 15(8):. PubMed ID: 36015152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of muco-adhesive orally disintegrating tablets containing tamarind gum-coated tea powders for oral care.
    Kiniwa R; Miyake M; Kimura SI; Itai S; Kondo H; Iwao Y
    Int J Pharm X; 2019 Dec; 1():100012. PubMed ID: 31517277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Orally disintegrating tablets and orally disintegrating mini tablets - novel dosage forms for pediatric use.
    Comoglu T; Dilek Ozyilmaz E
    Pharm Dev Technol; 2019 Sep; 24(7):902-914. PubMed ID: 31215850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of novel multi-channel orally disintegrating tablets.
    Yu J; Shan X; Chen S; Sun X; Song P; Zhao R; Hu L
    Eur J Pharm Sci; 2020 Jan; 142():105108. PubMed ID: 31669391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
    Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
    Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of palatability of 10 commercial amlodipine orally disintegrating tablets by gustatory sensation testing, OD-mate as a new disintegration apparatus and the artificial taste sensor.
    Uchida T; Yoshida M; Hazekawa M; Haraguchi T; Furuno H; Teraoka M; Ikezaki H
    J Pharm Pharmacol; 2013 Sep; 65(9):1312-20. PubMed ID: 23927469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of Texture Analysis Technique in Formulation Development of Lyophilized Orally Disintegrating Tablets Containing Mannitol, Polyvinylpyrrolidone and Amino Acids.
    Hackl E; Ermolina I
    AAPS PharmSciTech; 2019 Jan; 20(2):71. PubMed ID: 30631978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods.
    Kashiwagura Y; Takusagawa S; Ikematsu Y; Tanaka S; Namiki N; Uchida S
    Acta Pharm; 2023 Mar; 73(1):107-119. PubMed ID: 36692467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.